Jennerex Biotherapeutics

About:

Jennerex is a clinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer.

Website: http://www.jennerex.com

Top Investors: Ottawa Regional Cancer Foundation

Description:

Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead product JX-594, currently in an international Phase 2 trial for primary liver cancer and colorectal cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse array of common cancers.